{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:14:37Z","timestamp":1767849277034,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010929","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:00:00Z","timestamp":1390435200000}}],"reference-count":29,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010929.pub2","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T08:05:57Z","timestamp":1390464357000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Yellow fever vaccine for patients with HIV infection"],"prefix":"10.1002","volume":"2014","author":[{"given":"Hilary","family":"Barte","sequence":"first","affiliation":[{"name":"University of California, San Francisco; Global Health Sciences; 50 Beale Street, Suite 1200 San Francisco California USA 94122"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara H","family":"Horvath","sequence":"additional","affiliation":[{"name":"University of California, San Francisco; Global Health Sciences; 50 Beale Street, Suite 1200 San Francisco California USA 94122"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George W","family":"Rutherford","sequence":"additional","affiliation":[{"name":"University of California, San Francisco; Global Health Sciences; 50 Beale Street, Suite 1200 San Francisco California USA 94122"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,1,23]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD010929.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/QAI.0b013e318249de59","article-title":"Plasma HIV-RNA is the key determinant of long-term antibody persistence after yellow fever immunization in a cohort of 364 HIV-infected patients","volume":"59","author":"Pacanowski","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"12","key":"10.1002\/14651858.CD010929.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00006454-199712000-00015","article-title":"Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1","volume":"16","author":"Sibailly","year":"1997 Dec","journal-title":"Pediatr Infect Dis J."},{"issue":"5","key":"10.1002\/14651858.CD010929.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","article-title":"Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients","volume":"48","author":"Veit","journal-title":"Clin Infect Dis."},{"issue":"5","key":"10.1002\/14651858.CD010929.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho","year":"2004 Oct","journal-title":"Rev Saude Publica."},{"issue":"16","key":"10.1002\/14651858.CD010929.pub2-BIB0005|cit5","first-page":"3118","article-title":"Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213\/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program","volume":"25","author":"Collaborative Group for Studies with Yellow Fever Vaccine","journal-title":"Vaccine."},{"key":"10.1002\/14651858.CD010929.pub2-BIB0006|cit6","first-page":"145","article-title":"Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus","volume":"2","author":"Goujon","year":"1995","journal-title":"J Trav Med"},{"issue":"1","key":"10.1002\/14651858.CD010929.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/apc.2007.0059","article-title":"Vaccination in Brazilian HIV-infected adults: a cross-sectional study","volume":"22","author":"Ho","year":"2008 Jan","journal-title":"AIDS Patient Care STDs."},{"key":"10.1002\/14651858.CD010929.pub2-BIB0008|cit8","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thailand"},{"issue":"5","key":"10.1002\/14651858.CD010929.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002 May","journal-title":"Am J Trop Med Hyg."},{"issue":"3","key":"10.1002\/14651858.CD010929.pub2-BIB0010|cit10","first-page":"200","article-title":"Safety and efficacy of yellow fever vaccine in children less than one-year-old","volume":"9","author":"Osinusi","year":"1990 Jul-Sep","journal-title":"West Afr J Med."},{"key":"10.1002\/14651858.CD010929.pub2-BIB0011|cit11","first-page":"238","article-title":"Immunogenicity and tolerance to yellow fever vaccine in travelers living with HIV, France","volume":"25\/26","author":"Pistone","year":"2007","journal-title":"Bull Epidemiol Hebdomadaire"},{"issue":"6","key":"10.1002\/14651858.CD010929.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/157016210793499277","article-title":"Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients","volume":"8","author":"Pistone","year":"2010 Sep","journal-title":"Curr HIV Res."},{"issue":"3","key":"10.1002\/14651858.CD010929.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1086\/314031","article-title":"Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases","volume":"31","author":"Receveur","year":"2000 Sep","journal-title":"Clin Infect Dis."},{"issue":"2","key":"10.1002\/14651858.CD010929.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4161\/hv.4.2.5216","article-title":"Evaluation of two yellow fever vaccines for routine immunization programs in Argentina","volume":"4","author":"Ripoll","year":"2008 Mar-Apr","journal-title":"Hum Vaccin."},{"issue":"4","key":"10.1002\/14651858.CD010929.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial","volume":"3","author":"Roukens","journal-title":"PLoS One."},{"issue":"7","key":"10.1002\/14651858.CD010929.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.trstmh.2012.04.002","article-title":"Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali","volume":"106","author":"Sidibe","year":"2012 Jul","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"5","key":"10.1002\/14651858.CD010929.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00002030-200403260-00020","article-title":"Yellow fever vaccine is safe and effective in HIV-infected patients","volume":"18","author":"Tattevin","journal-title":"AIDS."},{"issue":"2","key":"10.1002\/14651858.CD010929.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review","volume":"86","author":"Thomas","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1002\/14651858.CD010929.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/hiv.09.52","article-title":"Yellow fever vaccination in HIV-infected patients","volume":"4","author":"Veit","year":"2010 Jan","journal-title":"HIV Ther."},{"issue":"RR-7","key":"10.1002\/14651858.CD010929.pub2-BIB0020|cit20","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"10.1002\/14651858.CD010929.pub2-BIB0021|cit21","unstructured":"Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann GRADEpro, Version 3.2 for Windows 2011"},{"issue":"7650","key":"10.1002\/14651858.CD010929.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","journal-title":"BMJ."},{"key":"10.1002\/14651858.CD010929.pub2-BIB0023|cit23","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD010929.pub2-BIB0024|cit24","unstructured":"Wells GA Shea B O'Connell D Peterson J Welch V Losos M Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp [accessed 7 January 2014]"},{"issue":"12","key":"10.1002\/14651858.CD010929.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999 Dec","journal-title":"Trop Med Int Health."},{"key":"10.1002\/14651858.CD010929.pub2-BIB0026|cit26","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) version 5.1 2011"},{"key":"10.1002\/14651858.CD010929.pub2-BIB0027|cit27","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS) Global Report, 2013 Available from: http:\/\/www.unaids.org\/en\/resources\/campaigns\/globalreport2013\/ [accessed 7 January 2014] 2013"},{"key":"10.1002\/14651858.CD010929.pub2-BIB0028|cit28","unstructured":"World Health Organization (WHO) Health Topics: Yellow Fever Available from: http:\/\/www.who.int\/topics\/yellow_fever\/en\/ [accessed 17 December 2013]"},{"key":"10.1002\/14651858.CD010929.pub2-BIB0029|cit29","unstructured":"World Health Organization (WHO) Global and Alert Response (GAR): Vaccines and vaccination against yellow fever Available from: http:\/\/www.who.int\/csr\/resources\/publications\/yellowfever\/ [accessed 7 January 2013]"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T13:32:14Z","timestamp":1720877534000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010929.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010929.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,23]]}}}